Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT05062655
NA

Interest of Drug Reconciliation to Ensure the Continuity of the Treatment at Discharge

Sponsor: Centre Hospitalier le Mans

View on ClinicalTrials.gov

Summary

From a regulatory point of view, medication reconciliation is a necessary process to ensure safe medication management for patients. According to national studies and the international scientific literature, the information received by patients and health professionals at discharge from hospital is insufficient. Medication reconciliation at discharge reduces medication errors and rehospitalisation, but few studies have been conducted on the impact of a coordinated and reliable care pathway on medication continuity. The iCoCon study will enable a new healthcare organisation to be set up in order to improve the quality of the patient pathway and the patient's medication management. This new organisation is part of the policy of continuous improvement of the quality and safety of care

Official title: Nterest of Drug Reconciliation to Ensure the Continuity of the Treatment at Discharge

Key Details

Gender

All

Age Range

Any - Any

Study Type

INTERVENTIONAL

Enrollment

82

Start Date

2021-11-08

Completion Date

2022-11-12

Last Updated

2026-07-01

Healthy Volunteers

No

Interventions

OTHER

Drug reconciliation

Drug reconciliation information transmission to pharmacist interview with the patient

Locations (1)

Centre Hospitalier Du Mans

Le Mans, France